Completed OBSERVATIONAL NCT03828162

Atrial Fibrillation: Risk and Benefits of Anti-coagulation in the Elderly (Carebbean-e)

Analysis of the Risk and Benefits of Anti-coagulation in Elderly Patients (>=75 Years)

Sponsor: Karolinska Institutet

Conditions Anticoagulants Causing Adverse Effects in Therapeutic Use Atrial Fibrillation Frail Elderly Syndrome

Updated 4 times since 2019 Last updated: Jan 31, 2019 Started: Nov 1, 2010 Primary completion: Dec 31, 2017 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Anticoagulants Causing Adverse Effects in Therapeutic Use and Atrial Fibrillation and is currently completed. Karolinska Institutet leads this study, which shows 4 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Mar 2019 — Jan 2021 [monthly]

Completed

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karolinska Institutet

Data source: Karolinska Institutet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.